Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
June 03 2004 - 8:30AM
PR Newswire (US)
Amylin Pharmaceuticals to Present at Goldman Sachs Global
Healthcare Conference SAN DIEGO, June 3 /PRNewswire-FirstCall/ --
Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at
the Goldman Sachs Global Healthcare Conference on Tuesday, June 8,
2004 at 4:40 p.m. Pacific Time at The Ritz-Carlton in Dana Point,
California. Mark G. Foletta, Vice President, Finance and Chief
Financial Officer of Amylin Pharmaceuticals, will be providing a
corporate overview. The live presentation and breakout session will
both be webcast, and recordings will be made available following
the events. The webcasts and recordings will be accessible through
Amylin's corporate website, located at http://www.amylin.com/. To
access the live webcasts, please log on to Amylin's site
approximately fifteen minutes prior to the presentation to register
and download any necessary audio software. Amylin Pharmaceuticals
is committed to improving the lives of people with diabetes and
other metabolic diseases through the discovery, development and
commercialization of innovative, cost-effective medicines.
DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta,
Vice President of Finance and Chief Financial Officer of Amylin
Pharmaceuticals, Inc., +1-858-552-2200 Web site:
http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024